When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Take-home naloxone program - Wikipedia

    en.wikipedia.org/wiki/Take-Home_Naloxone_Program

    Naloxone was created in a laboratory, patented in 1961, and approved by the FDA a decade later. [1] It was first proposed in the 1990s for community-based provisions of take-home naloxone rescue kits (THN) to opioid users, which involved training opioid users, along with their family or friends, in awareness, emergency management, and administration of naloxone. [2]

  3. Vaccine Information Statement - Wikipedia

    en.wikipedia.org/wiki/Vaccine_Information_Statement

    CDC Vaccine Information Statement for MMR Vaccine from April 2012. According to the 1993 amended National Childhood Vaccine Injury Act (NCVIA), a VIS must contain at least the following four components: (1) a description of the benefits of the given vaccine, (2) a description of its risks, (3) information about the National Vaccine Injury Compensation Program (VICP), and (4) other relevant ...

  4. Naloxone - Wikipedia

    en.wikipedia.org/wiki/Naloxone

    Naloxone is a non-selective and competitive opioid receptor antagonist. [6] [17] It reverses the depression of the central nervous system and respiratory system caused by opioids. [13] Naloxone was patented in 1961 and approved for opioid overdose in the United States in 1971. [18] [19] It is on the World Health Organization's List of Essential ...

  5. File:CDC Vaccine Information Statement for MMR Vaccine.pdf

    en.wikipedia.org/wiki/File:CDC_Vaccine...

    This file is a work of the Centers for Disease Control and Prevention, part of the United States Department of Health and Human Services, taken or made as part of an employee's official duties. As a work of the U.S. federal government , the file is in the public domain .

  6. Naloxone - Wikipedia

    en.wikipedia.org/wiki/(+)-Naloxone

    (+)-Naloxone (dextro-naloxone) is a drug which is the opposite enantiomer of the opioid antagonist drug (−)-naloxone. Unlike (−)-naloxone, (+)-naloxone has no significant affinity for opioid receptors , [ 1 ] but instead has been discovered to act as a selective antagonist of Toll-like receptor 4 .

  7. Jack Fishman - Wikipedia

    en.wikipedia.org/wiki/Jack_Fishman

    Jack Fishman (September 30, 1930 – December 7, 2013), born Jacob Fiszman, was a Jewish-American pharmaceutical researcher from Kraków, Poland. [1] In 1961, along with Mozes J. Lewenstein, he developed the medication naloxone, which can reverse an opioid overdose, and the Centers for Disease Control and Prevention has described as a "a life-saving medication that can reverse an overdose from ...

  8. File:Excerpt from CDC 2003 Table 1.pdf - Wikipedia

    en.wikipedia.org/wiki/File:Excerpt_from_CDC_2003...

    This file is a work of the Centers for Disease Control and Prevention, part of the United States Department of Health and Human Services, taken or made as part of an employee's official duties. As a work of the U.S. federal government, the file is in the public domain.

  9. National Center for Health Statistics - Wikipedia

    en.wikipedia.org/wiki/National_Center_for_Health...

    NCHS's National Immunization Survey is conducted in collaboration with other CDC offices in Atlanta. NCHS's National Death Index creates a longitudinal component to other routine data systems. NCHS's Questionnaire Design Research Laboratory develops and tests survey and data collection instruments for use by NCHS and other federal agencies and ...